Subex Ltd.’s revenue in Q3FY23 fell 16% to ₹ 7,366 lakhs. Consolidated Loss After Tax came at ₹ 468 lakhs. In this quarter’s results, the reports suggested that the fall in profits are due to the high level of expenses along with high levels of provisions and taxes.
Subex Limited Q3FY23; 16% Fall in Revenue

Related Post
- Aurobindo Pharma Ltd Q4FY25; 0% fall in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals…
-
Astral Ltd Q4FY25; 2% fall in Profits
Astral Poly Technik Ltd was established in 1996, with the aim to manufacture pro-India plumbing…
-
Astrazeneca Pharma India Ltd Q4FY25; 3% rise in Revenue
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of…